- Home
- ANTA vs ACHV Comparison
ANTA vs ACHV Comparison
Compare ANTA & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTA | ACHV |
|---|---|---|
| Founded | 2022 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.7M | 233.2M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ANTA | ACHV |
|---|---|---|
| Price | $7.26 | $2.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $16.17 | $15.50 |
| AVG Volume (30 Days) | 2.5K | ★ 322.2K |
| Earning Date | 03-03-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.57 | N/A |
| Revenue Next Year | $30.46 | N/A |
| P/E Ratio | $19.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $1.84 |
| 52 Week High | $15.65 | $6.03 |
Technical Indicators
Market Signals| Indicator | ANTA | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 26.15 | 23.45 |
| Support Level | $6.80 | $2.38 |
| Resistance Level | $9.98 | $3.39 |
| Average True Range (ATR) | 0.33 | 0.24 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 20.93 | 1.68 |
Price Performance
Historical ComparisonAbout ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.